Copyright © 1996 by the European Society of Cardiology.
© 1996 The European Society of Cardiology
Effects of captopril on ventricular arrhythmias in the early and late phase of suspected acute myocardial infarction
Randomized, placebo-controlled substudy of ISIS-4
niewski
y
ski
Postgraduate Medical School, Grochowski Hospital Warsaw, Poland
*Dietla Hospital Cracow, Poland
revised 19 January 1996; accepted 15 February 1996.
Andrzej Budaj, MD, Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Grenadierów 51/59, 04/073 Warsaw, Poland.
Abstract
The antiarrhythmic effect of oral captopril was studied during the early (day 3) and late (day 14) phase of acute myocardial infarction among 304 patients in a randomized placebo-controlled substudy of ISIS-4.
Ventricular arrhythmias (ventricular ectopic beats per hour) occurred significantly less frequently among captopril-allocated patients than among those allocated placebo at day 3 (logarithmic scale: 0·48 ± 0·8 captopril vs 0·84 ± 1·3 placebo; P<0·003) and at day 14 (0·51 ± 1·0 vs 0·77 ± 1·3; P<0·05). The number of patients with frequent ventricular arrhythmias (more than 10 ventricular ectopic beats per hour) was also significantly lower among those allocated captopril at day 3 (7·3% vs 14·4% P<0·05) and at day 14 (7·3% vs 14·8%; P<0·05).
These results support the hypothesis that the activation of the renin-angiotensin-aldosterone and sympathetic system may underlie heart rhythm disturbances in acute myocardial infarction, and that early use of converting enzyme inhibitor therapy may ameliorate these disturbances.
(Eur Heart J 1996; 17: 15061510)
Key Words: Myocardial infarction ventricular arrhythmias ACE inhibitors captopril antiarrhythmic effect
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. R. Ehrlich, S. H. Hohnloser, and S. Nattel Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence Eur. Heart J., March 1, 2006; 27(5): 512 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. McMurray, L. Kober, M. Robertson, H. Dargie, W. Colucci, J. Lopez-Sendon, W. Remme, D. N. Sharpe, and I. Ford Antiarrhythmic effect of carvedilol after acute myocardial infarction: Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial J. Am. Coll. Cardiol., February 15, 2005; 45(4): 525 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. D. Pedersen, H. Bagger, L. Kober, and C. Torp-Pedersen Trandolapril Reduces the Incidence of Atrial Fibrillation After Acute Myocardial Infarction in Patients With Left Ventricular Dysfunction Circulation, July 27, 1999; 100(4): 376 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Newby, T. Thompson, A. Stebbins, E. J. Topol, R. M. Califf, and A. Natale Sustained Ventricular Arrhythmias in Patients Receiving Thrombolytic Therapy : Incidence and Outcomes Circulation, December 8, 1998; 98(23): 2567 - 2573. [Abstract] [Full Text] [PDF] |
||||


